Proliferative Diabetic Retinopathy Linked To Coronary Artery Calcium

Monday, June 9, 2008

Comments

Endocrinetoday

Risk factors that link diabetic retinopathy in type 2 diabetes to coronary atherosclerosis should be identified and treated, according to results of recent data.

Full Story

Retina Products and Equipment »

All of the following drugs are FDA approved for the treatment of minimally classic subfoveal CNV in patients with neovascular AMD with evidence of recent disease progression (loss of vision, growth of CNV on FA, new macular hemorrhage) except for which one?
1. Pegaptanib sodium (Macugen)
2. Verteporfin (Visudyne PDT)
3. Ranibizumab (Lucentis)
4. None of the above
5. All of the above
Check The Answer

3nethra classic Ophthalmic Imaging Device
The 3nethra classic is a compact, ... view product
SPECTRALIS Diagnostic Imaging Platform
A modular and upgradeable ophthalmic ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Proliferative Diabetic Retinopathy Linked To Coronary Artery Calcium

Comments

Related Categories

Retina Products and Equipment »

Quick Quiz

All of the following drugs are FDA approved for the treatment of minimally classic subfoveal CNV in patients with neovascular AMD with evidence of recent disease progression (loss of vision, growth of CNV on FA, new macular hemorrhage) except for which one?

AdGlare RMR Ad

Featured Products

3nethra classic Ophthalmic Imaging Device

SPECTRALIS Diagnostic Imaging Platform

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us